Application no. and date | 06838635.8 (espacenet) (Federated) (European Patent Register), 20061129 | Patent/reg. no. and date | DK/EP 1968594, 20100929 | Publication date | 20080917 | Priority no. and date | US 740478 P, 20051129 | EP pub. no. and date |
EP 1968594 20080917 | Effective date | | Applicant/owner | GlaxoSmithKline LLC, One Franklin Plaza 200 North 16th Street
Philadelphia, PA 19102, US | Applicant ref. no. | 154363 | Inventor | BRIGANDI, Richard Anthony, GlaxoSmithKline c/o Corporate Intellectual Property Department 1250 Collegeville Road P.O. Box 5089
Collegeville, PA 19426, US, LEVICK, Mark, GlaxoSmithKline c/o Corporate Intellectual Property Department 1250 South Collegeville Road P.O. Box 5089
Collegeville, PA 19426, US, MILLER, William Henry, GlaxoSmithKline c/o Corporate Intellectual Property Department 1250 South Collegeville Road P.O. Box 5089
Collegeville, PA 19426, US | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/506 (2006.01) , A61K 31/55 (2006.01) , A61P 27/02 (2006.01) | Title | Behandling af okulære neovaskulære lidelser, såsom makulær degeneration, striae angioides og makulært ødem | Int. application no. | US2006045776 | Int. publication no. | WO2007064752 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|